Nipent and multi-organ failure Patient Reports February 13, 2012

Nipent Side Effects Report #4819826-5
Nipent side effect was reported by a Physician from GERMANY on Oct 21, 2005. Male patient, 57 years of age, weighting 189.6 lb, was diagnosed with graft versus host disease and was treated with Nipent. After drug was administered, patient experienced the following side effects: alveolitis, blood bilirubin increased, bone marrow failure, cholestasis, dyspnoea, escherichia sepsis, haemodialysis, multi-organ failure, renal failure acute. Nipent dosage: (0.5 MG), INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, DECORTIN, KALINOR, NEXIUM, NITRO, NORVASC, AUGMENT, PANTOZOL. Patient died on 10/18/2005.

Nipent Side Effects Report #4899669-7
Nipent side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 19, 2006. Female patient, 64 years of age, weighting 128.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: body temperature increased, cardiac failure congestive, hypotension, multi-organ failure, oedema, pneumonia , pneumonitis, respiratory distress. Nipent dosage: 0.1905 MG/M2 (4MG/M2, EVERY 21 DAYS); INTRAVENOUS. During the same period patient was treated with RITUXIMAB, CYTOXAN, NEULASTA, ACYCLOVIR, AZITHROMYCIN, BACTRIM DS, LASIX, PREDNISONE. Patient was hospitalized. Patient died.

Nipent Side Effects Report #5074479-9
Nipent side effect was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2006. Male patient, 61 years of age, weighting 200.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: bacteria blood identified, corynebacterium infection, hypersensitivity, hypotension, multi-organ failure, pyrexia, sepsis , staphylococcal infection . Nipent dosage: -- (4 MG/M2, CLD1, C2-6D1), INTRAVENOUS. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died.